Cyperus Biogenics Private Limited
About Cyperus Biogenics Private Limited
Data last updated:
Cyperus Biogenics Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2019PTC231316. Its GSTIN is 19AAICC1139P1Z8 (West Bengal).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pijush Kanti Dutta and Mithu Dutta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mohit Colony 24 (P – 17) Bosepara Road, Kolkata, West Bengal, India – 700008.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.98 Lakh, a decline of 62% compared to the previous year. For the same year it recorded a net loss of ₹12.96 Lakh (net margin -72.1%) and EBITDA of -₹12.35 Lakh (EBITDA margin -68.7%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressMohit Colony 24 (P – 17) Bosepara Road, Kolkata, West Bengal, India – 700008
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cyperus Biogenics Private Limited
The main business activity of Cyperus Biogenics is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cyperus Biogenics Private Limited FY 2025 filings available
Cyperus Biogenics Private Limited reported revenue of ₹17.98 Lakh (down 62% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Cyperus Biogenics Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 16% over three years, including a 62% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cyperus Biogenics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹12.35 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹12.96 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cyperus Biogenics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -68.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -72.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cyperus Biogenics are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cyperus Biogenics Private Limited
Cyperus Biogenics Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kalikund Syntex Ltd | ₹18 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Dist-Ahmedabad, Gujarat, India |
| Enkay Organics Private Limited | ₹18 Lakh (FY 2025) | •••• | •••• | 80.0% | •••• | Mumbai, Maharashtra, India |
| Granules Czro Private Limited | ₹18 Lakh (FY 2025) | •••• | •••• | 2900.0% | •••• | Hyderabad, Telangana, India |
| Bushal Health Care Private Limited | ₹18 Lakh (FY 2025) | •••• | •••• | 5144.0% | •••• | Badlapur, Maharashtra, India |
| Sudhin Biotech Private Limited | ₹17.99 Lakh (FY 2025) | •••• | •••• | 302.0% | •••• | Chennai, Tamil Nadu, India |
| Cyperus Biogenics Private Limited this company | ₹17.98 Lakh (FY 2024) | •••• | •••• | -62.0% | •••• | Kolkata, West Bengal, India |
| Rahul Pharma Ltd | ₹17.94 Lakh (FY 2025) | •••• | •••• | 140.0% | •••• | Mumbai, Maharashtra, India |
| Revitar Life Science Private Limited | ₹17.91 Lakh (FY 2024) | •••• | •••• | 145.0% | •••• | Surat, Gujarat, India |
| Ariskem Pharmaceuticals Private Limited | ₹17.87 Lakh (FY 2024) | •••• | •••• | -48.0% | •••• | Kesnand, Maharashtra, India |
| Geniqe Nutrition Private Limited | ₹17.75 Lakh (FY 2024) | •••• | •••• | 146.0% | •••• | Mumbai, Maharashtra, India |
| Balajee Meditech Private Limited | ₹17.69 Lakh (FY 2018) | •••• | •••• | 31.0% | •••• | Allahabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Cyperus Biogenics by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Cyperus Biogenics Private Limited
Cyperus Biogenics has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pijush Kanti Dutta Also directs: Almaz Infracon Private Limited | Director | 07 May 2021 | 5 Years 5 Months | Current |
| Mithu Dutta | Director | 07 May 2021 | 5 Years 5 Months | Current |
| Mohammad Babon Mir Also directs: Almaz Infracon Private Limited, Delbruck Ventures Private Limited | Director | 04 Apr 2019 | 7 Years 6 Months | Current |
| Habina Mir | Director | 04 Apr 2019 | 7 Years 6 Months | Current |
Ownership and Shareholding of Cyperus Biogenics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cyperus Biogenics Private Limited
Cyperus Biogenics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cyperus Biogenics Private Limited
Employment history and EPFO contributions of people linked to Cyperus Biogenics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cyperus Biogenics Private Limited
Cyperus Biogenics Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Mithu Dutta was appointed as Director on 07 May 2021.
Credit Ratings, Litigation & Regulatory Alerts for Cyperus Biogenics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cyperus Biogenics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cyperus Biogenics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cyperus Biogenics Private Limited
Cyperus Biogenics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAICC1139P1Z8 | West Bengal | Active | 24 Oct 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cyperus Biogenics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyperus Biogenics Private Limited
Cyperus Biogenics is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 April 2019 (7+ years old) and is registered under CIN U24239WB2019PTC231316.
Cyperus Biogenics reported revenue of ₹17.98 Lakh for FY 2024 (down 62% YoY).
Cyperus Biogenics has 4 current directors:
- Pijush Kanti Dutta - Director
- Mithu Dutta - Director
- Mohammad Babon Mir - Director
- Habina Mir - Director
Cyperus Biogenics reported a net loss of ₹12.96 Lakh (net margin -72.1%) and EBITDA of -₹12.35 Lakh (EBITDA margin -68.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cyperus Biogenics is -16% over three years. In the latest year (FY 2024) revenue fell 62%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cyperus Biogenics is 19AAICC1139P1Z8, registered in West Bengal.
The CIN (Corporate Identification Number) of Cyperus Biogenics is U24239WB2019PTC231316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cyperus Biogenics was incorporated on 04 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Cyperus Biogenics by revenue are Kalikund Syntex Ltd, Enkay Organics Private Limited, Granules Czro Private Limited, Bushal Health Care Private Limited, Sudhin Biotech Private Limited and 5 more, all in the Pharma industry (Formulations).
Mithu Dutta was appointed as Director on 07 May 2021. Pijush Kanti Dutta was appointed as Director on 07 May 2021. Habina Mir was appointed as Director on 04 Apr 2019. Cyperus Biogenics has 4 board changes on record in total.
The registered office of Cyperus Biogenics is at Mohit Colony 24 P – 17 Bosepara Road, Kolkata, West Bengal, India – 700008.